ACST - Acasti Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Acasti Pharma's activity chart (see below) currently has 14 price targets and 16 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 10% of the time, taking 3.8 days on average.

Most recent stock forecast was given by OREN LIVNAT from on 26-Sep-2024. First documented stock forecast 26-Jun-2019.

Best performing analysts who are covering ACST - Acasti Pharma:

Leland Gershell Mayank Mamtani Oren Livnat Nathan Weinstein Andrew Fein

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 12-Jul-2023

$12

$12

2 years 1 months 27 days ago
(26-Sep-2024)

0/2 (0%)

$8.93 (290.88%)

Buy Since 18-Jul-2019

$29.41

$30

4 years 5 months ago
(22-Jun-2022)

0/5 (0%)

$24 (443.62%)

Buy Since 09-Jul-2019

$12

$144

6 years 2 months 20 days ago
(02-Sep-2020)

1/2 (50%)

$1.58 (15.16%)

19

Buy Since 31-Aug-2020

$96

6 years 2 months 22 days ago
(31-Aug-2020)

0/2 (0%)

$66.72 (227.87%)

Buy Since 26-Jun-2019

$150

$288

6 years 9 months 4 days ago
(18-Feb-2020)

0/2 (0%)

$122.69 (449.25%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACST (Acasti Pharma) average time for price targets to be met?

On average it took 4 days for the stock forecasts to be reached, with an average price target met ratio of 10%.

Which analyst most recently updated their price target on ACST (Acasti Pharma)?

Oren Livnat

Which analyst has the lowest performance score on ACST (Acasti Pharma) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on ACST (Acasti Pharma)?

Oren Livnat works at HC WAINWRIGHT and has 4 price targets and 4 ratings on ACST

Which analyst is the currently most bullish on ACST (Acasti Pharma)?

Andrew Fein with the highest potential upside of $146.63

Which analyst is the currently most reserved on ACST (Acasti Pharma)?

Mayank Mamtani with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?